CGAS and neoplasm: Persistent DNA damage caused by defective breast cancer gene (BRCA) pathway (disrupted BRCA1-PALB2 interaction) induces tumor immunosuppression through the cGAS-STING pathway, while also promoting T-lymphocyte infiltration.